Please use this identifier to cite or link to this item: http://10.9.150.37:8080/dspace//handle/atmiyauni/702
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPandya, Darshana.-
dc.contributor.authorPatel, Madhavi.-
dc.contributor.authorGhediya, Ravi.-
dc.contributor.authorShah, Anamik.-
dc.contributor.authorKhunt, Ranjan.-
dc.date.accessioned2021-08-18T11:50:47Z-
dc.date.available2021-08-18T11:50:47Z-
dc.date.issued2016-03-01-
dc.identifier.citationPandya, D., Patel, M., Ghediya, R., Shah, A., & Khunt, R. (2016). UV-Vis spectrophotometric assay determination of oral antiplatelet ticagrelor drug in pharmaceutical formulation: Application to content uniformity. Journal of Chemical and Pharmaceutical Research, 8(1), 316-321.en_US
dc.identifier.issn0975-7384-
dc.identifier.urihttps://www.jocpr.com/archive/jocpr-volume-8-issue-1-year-2016.html-
dc.identifier.urihttp://10.9.150.37:8080/dspace//handle/atmiyauni/702-
dc.description.abstractThe purpose of this study is to develop and validate a spectroscopic method for the antiplatelet drug, Ticagrelor. The method was performed on Pharmaco-model of UV–Spectrophotometer Shimadzu1700. The method was validated as per the ICH guidelines and results of this method were superior over the other reported method.en_US
dc.language.isoen_USen_US
dc.publisherJournal of Chemical and Pharmaceutical Researchen_US
dc.subjectUV-Vis Spectrophotometer, Method Development, and Validation, Ticagrelor, Formulation, Content Uniformity.en_US
dc.titleUV-Vis spectrophotometric assay determination of oral antiplatelet ticagrelor drug in pharmaceutical formulation: Application to content uniformityen_US
dc.typeArticleen_US
Appears in Collections:01. Journal Articles

Files in This Item:
File Description SizeFormat 
VSC_CHE_FJA_52.pdf318.21 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.